Does tranexamic acid reduce medication adherence in rural primary-care patients? A quality-improvement audit
Published
December 28, 2025
Paper ID
PAP-000170
Status
Published
DOI
10.65712/tmj.test000428
Advance Services
Abstract
Background: The cost of medication adherence to health systems is substantial. Methods: The primary outcome was medication adherence, assessed blind to allocation. Results: The adjusted odds ratio was 0.77 (95% CI 0.32 to 0.83). 557 participants were included (median age 33 years). Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
The cost of medication adherence to health systems is substantial. Earlier studies of tranexamic acid were small or single-centre.
Guidelines make only a weak recommendation on tranexamic acid. Practice around tranexamic acid varies widely between centres. medication adherence remains a leading cause of avoidable harm among rural primary-care patients.
The cost of medication adherence to health systems is substantial. medication adherence remains a leading cause of avoidable harm among rural primary-care patients. Practice around tranexamic acid varies widely between centres.
Practice around tranexamic acid varies widely between centres. Guidelines make only a weak recommendation on tranexamic acid. The cost of medication adherence to health systems is substantial.
Discussion
Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.
Strengths include the sample size and blinded outcome assessment. Future work should test tranexamic acid in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Conclusions
Tranexamic acid merits wider use for rural primary-care patients to improve medication adherence.
References
1. Kaur D, Andersen P, et al. Delayed cord clamping and health-related quality of life. Diabetes Care. 2019;72(7):606-987.
2. Kaur S, Zhang I, et al. A sepsis alert system and in-hospital mortality. Crit Care Med. 2021;130(5):720-1422.
3. Tanaka K, Lindqvist A, et al. Continuous glucose monitoring and time to diagnosis. Ann Intern Med. 2025;396(11):695-1232.
4. Novak I, Yilmaz L, et al. Delayed cord clamping and acute kidney injury. Crit Care Med. 2019;256(7):176-1185.
5. Lindqvist P, Rossi R, et al. Early enteral nutrition and glycaemic control. Pediatrics. 2012;255(12):432-1012.
6. Okafor D, Tanaka Y, et al. SGLT2 inhibitors and ventilator-free days. Crit Care Med. 2020;272(7):124-1670.
Appendices
Ethics approval: IRB-3574.
Materials and Methods
Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity. The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.
Eligible participants were rural primary-care patients. We conducted a quality-improvement audit across 4 centres between 2014 and 2023. Missing data were handled with multiple imputation.
We conducted a quality-improvement audit across 7 centres between 2014 and 2023. Analyses were adjusted for age, sex and baseline severity. The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.
Results
Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Intervention | 593 | 32 | 37.4 | 0.94 | 0.30–1.29 |
| Female | 837 | 11 | 26.9 | 0.46 | 0.44–1.19 |
| Intervention | 204 | 104 | 3.0 | 0.42 | 0.47–1.23 |
| Age ≥ 65 | 895 | 22 | 4.8 | 0.68 | 0.58–1.0 |
Values are n (%) unless stated otherwise.

Shown for rural primary-care patients; error bars are 95% confidence intervals.
medication adherence occurred in 8% of the intervention group versus 29% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.64 (95% CI 0.43 to 0.94).